Ms Nadia Mazarakis
Honorary (Fellow)
Department of Paediatrics
13 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial
DOI: 10.1016/j.vaccine.2025.1278402025
Journal article
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose
DOI: 10.1016/j.jinf.2025.1064472025
Journal article
Evaluation of SARS-CoV-2 Antibody Response Between Paired Fingerprick (HemaPEN®) and Venepuncture Collected Samples in Children and Adults
DOI: 10.3390/antib140100132025
Journal article
Immunogenicity of fractional and standard dose COVID-19 vaccine boosters among healthy adults in Indonesia: twenty four month follow-up from a randomised controlled trial
DOI: 10.1038/s41467-025-63598-62024
Journal article
A 38-colour high dimensional immunophenotyping panel for human peripheral blood mononuclear cells
DOI: 10.1016/j.jim.2024.1137262024
Journal article
Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial
DOI: 10.1016/j.eclinm.2024.1026162024
Journal article
Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trial
DOI: 10.1016/j.ebiom.2024.105100
RECENT SCHOLARLY WORKS
2024
Journal article
Impaired IgM Memory B Cell Function Is Common in Coeliac Disease but Conjugate Pneumococcal Vaccination Induces Robust Protective Immunity
DOI: 10.3390/vaccines120202142024
Journal article
Immunogenicity, safety, and reactogenicity of a halfversus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial
DOI: 10.1016/j.lanwpc.2023.1009532024
Journal article
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS-CoV-2 Omicron infection
DOI: 10.1002/cti2.70008